Abstract

The Australian National COVID-19 Clinical Evidence Taskforce was established in March 2020 to maintain up-to-date recommendations for the treatment of people with coronavirus disease 2019 (COVID-19). The original guideline (April 2020) has been continuously updated and expanded from nine to 176 recommendations, facilitated by the rapid identification, appraisal, and analysis of clinical trial findings and subsequent review by expert panels.

Authors	White, H; McDonald, SJ; Barber, B; Davis, J; Burr, L; Nair, P; Mukherjee, S; Tendal, B; Elliott, J; McGloughlin, S; Turner, T
Journal	MEDICAL JOURNAL OF AUSTRALIA
Pages	368-378
Volume	217
Date	3/10/2022
Grant ID	Department of Health, Australian Government; Ian Potter Foundation; Lord Mayor's Charitable Foundation; Victorian Government Department of Health and Human Services; Walter Cottman Endowment Fund
Funding Body
URL	http://www.ncbi.nlm.nih.gov/pubmed/?term=10.5694/mja2.51718